# US 2023/0265120 A1 · Nucleoside derivative and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0265120 A1
- Document ID: US20230265120A1
- Status: Published application
- Kind: A1
- Application number: 18/186,235
- Filed: 2023-03-20
- Published: 2023-08-24
- Earliest claimed: 2016-12-16
- Assignees: National University Corporation Tokai National Higher Education and Research System
- Applicants: National University Corporation Tokai National Higher Education and Research System
- Inventors: Yoshihito UENO
- Web page: https://patentgrep.com/patent/US20230265120A1

## CPC

- C07H 19/073: with 2-deoxyribosyl as the saccharide radical
- C07H 19/10: with the saccharide radical esterified by phosphoric or polyphosphoric acids
- A61K 47/26: Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A61P 35/00: Antineoplastic agents
- C07H 19/067: with ribosyl as the saccharide radical
- C07H 19/167: with ribosyl as the saccharide radical
- C07H 19/173: with 2-deoxyribosyl as the saccharide radical
- C07H 19/20: with the saccharide radical esterified by phosphoric or polyphosphoric acids
- C07H 21/02: with ribosyl as saccharide radical
- C07H 21/04: with deoxyribosyl as saccharide radical
- C12N 15/09: Recombinant DNA-technology
- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- C12N 2310/14: interfering nucleic acids [NA]
- C12N 2310/141: MicroRNAs, miRNAs
- C12N 2310/321: 2'-O-R Modification
- C12N 2310/322: 2'-R Modification
- Y02P 20/55: Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

A nucleoside derivative represented below, or a salt thereof. (In (1), R1 represents a hydrogen atom, a hydroxyl group or a protected group, and in (2), X represent a halogen atom. In (1) and (2), R2 and R4 each represent a hydrogen atom, a hydroxyl protecting, phosphate, or protected phosphate group, or —P(═O)nR5R6 (n is 0 or 1, R5 and R6 each representing a hydrogen atom, hydroxyl, protected hydroxyl, mercapto, protected mercapto, lower alkoxy, cyano lower alkoxy, amino or substituted amino group, when n is 1, R5 and R6 are not both hydrogen atoms), R3 represents NHR7 (R7 represents a hydrogen atom, alkyl, alkenyl or protecting group for an amino group), an azide, amidino or guanidino group, each having a linking group (when R7 is hydrogen atom, the linking group is an alkylene group), and B represents any of a purine-9-yl, 2-oxo-pyrimidin-1-yl, substituted purine-9-yl or substituted 2-oxo-pyrimidin-1-yl group.)

## Claims

### Claim 1

An oligonucleotide comprising a nucleoside derivative represented by formula (1) below, or a salt thereof:
wherein:
R1 represents a hydrogen atom, a hydroxyl group, a hydroxyl group in which a hydrogen atom is substituted by an alkyl group or alkenyl group, or a protected group;
R2 and R4 may be the same or different, and each represents:
a hydrogen atom,
a hydroxyl protecting group,
a phosphate group,
a protected phosphate group, or
—P(═O)nR5R6, wherein:
n is 0 or 1, and
R5 and R6 may be the same or different, with each representing a hydrogen atom, hydroxyl group, protected hydroxyl group, mercapto group, protected mercapto group, lower alkoxy group, cyano lower alkoxy group, amino group or substituted amino group, but when n is 1, R5 and R6 are not both hydrogen atoms;
R3 represents:
NHR7 wherein R7 represents a hydrogen atom, an alkyl group, an alkenyl group or a protecting group for an amino group,
an azide group,
an amidino group, or
a guanidino group,
each having a linking group, but when R7 is hydrogen atom or a protecting group for an amino group, the linking group is an alkylene group which has 2 to 3 carbon atoms; and
B represents a nucleobase.

### Claim 2 (depends on 1)

The oligonucleotide according to claim 1, wherein R1 represents a protected group.

### Claim 3 (depends on 2)

The oligonucleotide according to claim 2, wherein the protected group comprises fluorine.

### Claim 4 (depends on 2)

The oligonucleotide according to claim 2, wherein the protected group comprises methyl.

### Claim 5 (depends on 1)

The oligonucleotide according to claim 1, wherein said oligonucleotide is selected from the group consisting of a DNA molecule, a RNA molecule, and a duplex comprising a DNA and/or a RNA molecule.

### Claim 6 (depends on 1)

The oligonucleotide according to claim 1, wherein said oligonucleotide comprises a nucleoside derivative represented by the structure:
wherein P is a protecting group comprising fluorine.

### Claim 7 (depends on 1)

The oligonucleotide according to claim 1, wherein said oligonucleotide comprises a nucleoside derivative represented by the structure:

### Claim 8

An RNA molecule comprising a nucleoside derivative represented by formula (1) below, or a salt thereof:
wherein:
R1 represents a hydrogen atom, a hydroxyl group, a hydroxyl group in which a hydrogen atom is substituted by an alkyl group or alkenyl group, or a protected group;
R2 and R4 may be the same or different, and each represents:
a hydrogen atom,
a hydroxyl protection group,
a phosphate group,
a protected phosphate group, or
—P(═O)nR5R6, wherein:
n is 0 or 1, and
R5 and R6 may be the same or different, with each representing a hydrogen atom, hydroxyl group, protected hydroxyl group, mercapto group, protected mercapto group, lower alkoxy group, cyano lower alkoxy group, amino group or substituted amino group, but when n is 1, R5 and R6 are not both hydrogen atoms;
R3 represents:
NHR7, wherein R7 represents a hydrogen atom, an alkyl group, an alkenyl group or a protecting group for an amino group,
an azide group,
an amidino group, or
a guanidino group,
each having a linking group, but when R7 is hydrogen atom, the linking group is an alkylene group which has 2 to 3 carbon atoms; and
B represents any of a purine-9-yl group, 2-oxo-pyrimidin-1-yl group, substituted purine-9-yl group or substituted 2-oxo-pyrimidin-1-yl group; and
wherein said RNA molecule consists of an RNA interference agent.

### Claim 9 (depends on 8)

The RNA molecule according to claim 8, wherein said RNA molecule consists of a siRNA.

### Claim 10 (depends on 8)

The RNA molecule according to claim 8, wherein R7 represents a hydrogen atom.

### Claim 11 (depends on 8)

The RNA molecule according to claim 8, wherein R1 represents a protected group.

### Claim 12 (depends on 11)

The RNA molecule according to claim 11, wherein the protected group comprises fluorine.

### Claim 13 (depends on 11)

The RNA molecule according to claim 11, wherein the protected group comprises methyl.

### Claim 14 (depends on 8)

The RNA molecule according to claim 8, wherein the nucleoside derivative comprises the structure:

### Claim 15 (depends on 8)

The RNA molecule according to claim 8, wherein the nucleoside derivative comprises the structure:
wherein P is a protecting group.

### Claim 16 (depends on 15)

The RNA molecule according to claim 15, wherein P comprises fluorine.
